198 related articles for article (PubMed ID: 4119609)
1. Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.
Pittman JG; Maloof F
Am J Med Sci; 1972 Dec; 264(6):499-505. PubMed ID: 4119609
[No Abstract] [Full Text] [Related]
2. Thyroid gland in Graves' disease: victim or culprit?
Chopra IJ; Solomon DH; Johnson DE; Chopra U
Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
[No Abstract] [Full Text] [Related]
3. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease.
Cheron RG; Kaplan MM; Larsen PR; Selenkow HA; Crigler JF
N Engl J Med; 1981 Feb; 304(9):525-8. PubMed ID: 6893853
[No Abstract] [Full Text] [Related]
4. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
5. The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
Farid NR; Munro R; Row VV; Volpé R
Clin Endocrinol (Oxf); 1974 Jan; 3(1):55-61. PubMed ID: 4407296
[No Abstract] [Full Text] [Related]
6. Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs.
Refetoff S; Ochi Y; Selenkow HA; Rosenfield RL
J Pediatr; 1974 Aug; 85(2):240-4. PubMed ID: 4135477
[No Abstract] [Full Text] [Related]
7. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
McKenzie JM; Zakarija M; D'Amour P; Joasoo A
N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
[No Abstract] [Full Text] [Related]
8. In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil.
Van Loon AJ; Derksen JT; Bos AF; Rouwé CW
Prenat Diagn; 1995 Jul; 15(7):599-604. PubMed ID: 8532617
[TBL] [Abstract][Full Text] [Related]
9. Laboratory tests for evaluating thyroid therapy.
Kabadi UM
Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations.
Volpé R; Ehrlich R; Steiner G; Row VV
Am J Med; 1984 Sep; 77(3):572-8. PubMed ID: 6548082
[TBL] [Abstract][Full Text] [Related]
11. Relationships among immunoglobulin markers in Graves' disease.
Ozawa Y; Maciel RM; Chopra IJ; Solomon DH; Beall GN
J Clin Endocrinol Metab; 1979 Mar; 48(3):381-7. PubMed ID: 581874
[No Abstract] [Full Text] [Related]
12. Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
Sills IN; Horlick MN; Rapaport R
J Pediatr; 1992 Aug; 121(2):206-9. PubMed ID: 1640284
[TBL] [Abstract][Full Text] [Related]
13. Management of thyroid disorders.
Becker KL
Postgrad Med; 1973 Feb; 53(2):60-5. PubMed ID: 4688402
[No Abstract] [Full Text] [Related]
14. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
[No Abstract] [Full Text] [Related]
15. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
Chopra IJ; Chopra U; Orgiazzi J
J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
[No Abstract] [Full Text] [Related]
16. Antenatal diagnosis and treatment of fetal hypothyroidism. A report of two cases.
Bruner JP; Dellinger EH
Fetal Diagn Ther; 1997; 12(4):200-4. PubMed ID: 9354877
[TBL] [Abstract][Full Text] [Related]
17. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
Sawhney RC; Kannan V; Rastogi GK
J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
[No Abstract] [Full Text] [Related]
18. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
Momotani N; Noh JY; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
[TBL] [Abstract][Full Text] [Related]
19. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
20. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
Clifton-Bligh P; Burke G
J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
